CLINICAL_TRIALS ClinicalTrials.gov record update

Radiotherapy, Chemotherapy and Anti-PD-1 Immunotherapy Followed by Surgical Resection in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Prospective, Single Arm, Phase II Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06121700
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:29.406647+00:00
Published At: 2023-11-08T00:00:00+00:00
Record Updated At: 2023-11-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Adenocarcinoma", "Stomach Neoplasm", "Gastroesophageal-junction Cancer", "Oligometastatic Disease", "Metastatic Cancer", "Metastatic Gastric Cancer", "Adenocarcinoma of the Stomach", "Gastroesophageal Junction Adenocarcinoma", "Metastatic Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-11-08"
protocolSection.identificationModule.nctId: "NCT06121700"
protocolSection.identificationModule.officialTitle: "Radiotherapy, Chemotherapy and Anti-PD-1 Immunotherapy Followed by Surgical Resection in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Prospective, Single Arm, Phase II Trial"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.